Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1998 Feb;106(Suppl 1):159–169. doi: 10.1289/ehp.98106s1159

Selected new developments in asbestos immunotoxicity.

G J Rosenthal 1, E Corsini 1, P Simeonova 1
PMCID: PMC1533262  PMID: 9539011

Abstract

Research over the past three decades has shown that the mammalian immune system can be altered by the occupational exposure of asbestos. Early clinical studies generally focused on systemic observations of immune alteration such as the number and function of peripheral lymphocytes and monocytes. More recently as the regulatory influence of local immunity in health and disease becomes more defined, immunologic changes occurring in the lung, the primary target organ of asbestos, have been significant areas of investigation. This review will focus on recent studies that examine the influence of asbestos on pulmonary immunity as well as the role of host immune competence in asbestos-related disease.

Full text

PDF
159

Images in this article

162Figure 1
on p.162
162Figure 2
on p.162
163Figure 3
on p.163
165Figure 4
on p.165
165Figure 5
on p.165

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe E., Ishimi Y., Tanaka H., Miyaura C., Nagasawa H., Hayashi T., Suda T. The relationship between fusion and proliferation in mouse alveolar macrophages. Endocrinology. 1987 Jul;121(1):271–277. doi: 10.1210/endo-121-1-271. [DOI] [PubMed] [Google Scholar]
  2. Adamson I. Y., Letourneau H. L., Bowden D. H. Comparison of alveolar and interstitial macrophages in fibroblast stimulation after silica and long or short asbestos. Lab Invest. 1991 Mar;64(3):339–344. [PubMed] [Google Scholar]
  3. Archer V. E. Carcinogenicity of fibers and films: a theory. Med Hypotheses. 1979 Nov;5(11):1257–1262. doi: 10.1016/0306-9877(79)90008-2. [DOI] [PubMed] [Google Scholar]
  4. Aust S. D., Morehouse L. A., Thomas C. E. Role of metals in oxygen radical reactions. J Free Radic Biol Med. 1985;1(1):3–25. doi: 10.1016/0748-5514(85)90025-x. [DOI] [PubMed] [Google Scholar]
  5. Babior B. M., Kipnes R. S., Curnutte J. T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest. 1973 Mar;52(3):741–744. doi: 10.1172/JCI107236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Barbers R. G., Shih W. W., Saxon A. In vitro depression of human lymphocyte mitogen response (phytohaemagglutinin) by asbestos fibres. Clin Exp Immunol. 1982 Jun;48(3):602–610. [PMC free article] [PubMed] [Google Scholar]
  7. Bonner J. C., Goodell A. L., Coin P. G., Brody A. R. Chrysotile asbestos upregulates gene expression and production of alpha-receptors for platelet-derived growth factor (PDGF-AA) on rat lung fibroblasts. J Clin Invest. 1993 Jul;92(1):425–430. doi: 10.1172/JCI116584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brody A. R. Control of lung fibroblast proliferation by macrophage-derived platelet-derived growth factor. Ann N Y Acad Sci. 1994 May 28;725:193–199. doi: 10.1111/j.1749-6632.1994.tb39801.x. [DOI] [PubMed] [Google Scholar]
  9. Broser M., Zhang Y., Aston C., Harkin T., Rom W. N. Elevated interleukin-8 in the alveolitis of individuals with asbestos exposure. Int Arch Occup Environ Health. 1996;68(2):109–114. doi: 10.1007/BF00381242. [DOI] [PubMed] [Google Scholar]
  10. Bégin R., Drapeau G., Boileau R., Vézina Y., Cantin A., Desmarais Y., Martel M. Enzyme activities of lung lavage in asbestosis. Clin Biochem. 1986 Aug;19(4):240–243. doi: 10.1016/s0009-9120(86)80034-0. [DOI] [PubMed] [Google Scholar]
  11. Collart M. A., Baeuerle P., Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol. 1990 Apr;10(4):1498–1506. doi: 10.1128/mcb.10.4.1498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Corsini E., Luster M. I., Mahler J., Craig W. A., Blazka M. E., Rosenthal G. J. A protective role for T lymphocytes in asbestos-induced pulmonary inflammation and collagen deposition. Am J Respir Cell Mol Biol. 1994 Nov;11(5):531–539. doi: 10.1165/ajrcmb.11.5.7946383. [DOI] [PubMed] [Google Scholar]
  13. Crystal R. G., Gadek J. E., Ferrans V. J., Fulmer J. D., Line B. R., Hunninghake G. W. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med. 1981 Mar;70(3):542–568. doi: 10.1016/0002-9343(81)90577-5. [DOI] [PubMed] [Google Scholar]
  14. Davis J. M., Addison J., Bolton R. E., Donaldson K., Jones A. D., Smith T. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol. 1986 Jun;67(3):415–430. [PMC free article] [PubMed] [Google Scholar]
  15. Delclos G. L., Flitcraft D. G., Brousseau K. P., Windsor N. T., Nelson D. L., Wilson R. K., Lawrence E. C. Bronchoalveolar lavage analysis, gallium-67 lung scanning and soluble interleukin-2 receptor levels in asbestos exposure. Environ Res. 1989 Apr;48(2):164–178. doi: 10.1016/s0013-9351(89)80032-5. [DOI] [PubMed] [Google Scholar]
  16. Doll N. J., Diem J. E., Jones R. N., Rodriguez M., Bozelka B. E., Stankus R. P., Weill H., Salvaggio J. E. Humoral immunologic abnormalities in workers exposed to asbestos cement dust. J Allergy Clin Immunol. 1983 Nov;72(5 Pt 1):509–512. doi: 10.1016/0091-6749(83)90589-4. [DOI] [PubMed] [Google Scholar]
  17. Doll N. J., Diem J. E., Jones R. N., Rodriguez M., Bozelka B. E., Stankus R. P., Weill H., Salvaggio J. E. Humoral immunologic abnormalities in workers exposed to asbestos cement dust. J Allergy Clin Immunol. 1983 Nov;72(5 Pt 1):509–512. doi: 10.1016/0091-6749(83)90589-4. [DOI] [PubMed] [Google Scholar]
  18. Doll N. J., Diem J. E., Jones R. N., Rodriguez M., Bozelka B. E., Stankus R. P., Weill H., Salvaggio J. E. Humoral immunologic abnormalities in workers exposed to asbestos cement dust. J Allergy Clin Immunol. 1983 Nov;72(5 Pt 1):509–512. doi: 10.1016/0091-6749(83)90589-4. [DOI] [PubMed] [Google Scholar]
  19. Donaldson K., Miller B. G., Sara E., Slight J., Brown R. C. Asbestos fibre length-dependent detachment injury to alveolar epithelial cells in vitro: role of a fibronectin-binding receptor. Int J Exp Pathol. 1993 Jun;74(3):243–250. [PMC free article] [PubMed] [Google Scholar]
  20. Driscoll K. E., Hassenbein D. G., Carter J., Poynter J., Asquith T. N., Grant R. A., Whitten J., Purdon M. P., Takigiku R. Macrophage inflammatory proteins 1 and 2: expression by rat alveolar macrophages, fibroblasts, and epithelial cells and in rat lung after mineral dust exposure. Am J Respir Cell Mol Biol. 1993 Mar;8(3):311–318. doi: 10.1165/ajrcmb/8.3.311. [DOI] [PubMed] [Google Scholar]
  21. Dubois C. M., Bissonnette E., Rola-Pleszczynski M. Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Autoregulatory role of leukotriene B4. Am Rev Respir Dis. 1989 May;139(5):1257–1264. doi: 10.1164/ajrccm/139.5.1257. [DOI] [PubMed] [Google Scholar]
  22. El-Sewefy A. Z., Shaheen H., Shams El-Deen A. Bone marrow changes in asbestosis. Med Lav. 1974 May-Jun;65(5-6):168–173. [PubMed] [Google Scholar]
  23. Fischbein A., Suzuki Y., Selikoff I. J., Bekesi J. G. Unexpected longevity of a patient with malignant pleural mesothelioma: report of a case. Cancer. 1978 Oct;42(4):1999–2004. doi: 10.1002/1097-0142(197810)42:4<1999::aid-cncr2820420447>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  24. Gaumer H. R., Doll N. J., Kaimal J., Schuyler M., Salvaggio J. E. Diminished suppressor cell function in patients with asbestosis. Clin Exp Immunol. 1981 Apr;44(1):108–116. [PMC free article] [PubMed] [Google Scholar]
  25. Gauss-Müller V., Kleinman H. K., Martin G. R., Schiffmann E. Role of attachment factors and attractants in fibroblast chemotaxis. J Lab Clin Med. 1980 Dec;96(6):1071–1080. [PubMed] [Google Scholar]
  26. Gellert A. R., Langford J. A., Winter R. J., Uthayakumar S., Sinha G., Rudd R. M. Asbestosis: assessment by bronchoalveolar lavage and measurement of pulmonary epithelial permeability. Thorax. 1985 Jul;40(7):508–514. doi: 10.1136/thx.40.7.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ghio A. J., Kennedy T. P., Stonehuerner J. G., Crumbliss A. L., Hoidal J. R. DNA strand breaks following in vitro exposure to asbestos increase with surface-complexed [Fe3+]. Arch Biochem Biophys. 1994 May 15;311(1):13–18. doi: 10.1006/abbi.1994.1202. [DOI] [PubMed] [Google Scholar]
  28. Ghio A. J., Zhang J., Piantadosi C. A. Generation of hydroxyl radical by crocidolite asbestos is proportional to surface [Fe3+]. Arch Biochem Biophys. 1992 Nov 1;298(2):646–650. doi: 10.1016/0003-9861(92)90461-5. [DOI] [PubMed] [Google Scholar]
  29. Goodglick L. A., Kane A. B. Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages. Cancer Res. 1986 Nov;46(11):5558–5566. [PubMed] [Google Scholar]
  30. Goodglick L. A., Pietras L. A., Kane A. B. Evaluation of the causal relationship between crocidolite asbestos-induced lipid peroxidation and toxicity to macrophages. Am Rev Respir Dis. 1989 May;139(5):1265–1273. doi: 10.1164/ajrccm/139.5.1265. [DOI] [PubMed] [Google Scholar]
  31. Hardy J. A., Aust A. E. The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. Carcinogenesis. 1995 Feb;16(2):319–325. doi: 10.1093/carcin/16.2.319. [DOI] [PubMed] [Google Scholar]
  32. Harington J. S. Chemical studies of asbestos. Ann N Y Acad Sci. 1965 Dec 31;132(1):31–47. doi: 10.1111/j.1749-6632.1965.tb41088.x. [DOI] [PubMed] [Google Scholar]
  33. Hartmann D. P., Georgian M. M., Kagan E. Enhanced alveolar macrophage Ia antigen expression after asbestos inhalation. J Immunol. 1984 Jun;132(6):2693–2695. [PubMed] [Google Scholar]
  34. Hartmann D. P., Georgian M. M., Oghiso Y., Kagan E. Enhanced interleukin activity following asbestos inhalation. Clin Exp Immunol. 1984 Mar;55(3):643–650. [PMC free article] [PubMed] [Google Scholar]
  35. Haslam P. L., Lukoszek A., Merchant J. A., Turner-Warwick M. Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma. Clin Exp Immunol. 1978 Feb;31(2):178–188. [PMC free article] [PubMed] [Google Scholar]
  36. Hayes A. A., Venaille T. J., Rose A. H., Musk A. W., Robinson B. W. Asbestos-induced release of a human alveolar macrophage-derived neutrophil chemotactic factor. Exp Lung Res. 1990 Mar-Apr;16(2):121–130. doi: 10.3109/01902149009087877. [DOI] [PubMed] [Google Scholar]
  37. Herberman R. B. Natural killer (NK) cells and their possible roles in resistance against disease. Clin Immunol Rev. 1981;1(1):1–65. [PubMed] [Google Scholar]
  38. Holt P. G., Degebrodt A., Venaille T., O'Leary C., Krska K., Flexman J., Farrell H., Shellam G., Young P., Penhale J. Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays. Immunology. 1985 Jan;54(1):139–147. [PMC free article] [PubMed] [Google Scholar]
  39. Janssen Y. M., Barchowsky A., Treadwell M., Driscoll K. E., Mossman B. T. Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells. Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8458–8462. doi: 10.1073/pnas.92.18.8458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kagan E., Solomon A., Cochrane J. C., Kuba P., Rocks P. H., Webster I. Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity. Clin Exp Immunol. 1977 May;28(2):268–275. [PMC free article] [PubMed] [Google Scholar]
  41. Kamp D. W., Dunn M. M., Sbalchiero J. S., Knap A. M., Weitzman S. A. Contrasting effects of alveolar macrophages and neutrophils on asbestos-induced pulmonary epithelial cell injury. Am J Physiol. 1994 Jan;266(1 Pt 1):L84–L91. doi: 10.1152/ajplung.1994.266.1.L84. [DOI] [PubMed] [Google Scholar]
  42. Kamp D. W., Graceffa P., Pryor W. A., Weitzman S. A. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med. 1992;12(4):293–315. doi: 10.1016/0891-5849(92)90117-y. [DOI] [PubMed] [Google Scholar]
  43. Kamp D. W., Israbian V. A., Preusen S. E., Zhang C. X., Weitzman S. A. Asbestos causes DNA strand breaks in cultured pulmonary epithelial cells: role of iron-catalyzed free radicals. Am J Physiol. 1995 Mar;268(3 Pt 1):L471–L480. doi: 10.1152/ajplung.1995.268.3.L471. [DOI] [PubMed] [Google Scholar]
  44. Kang K., Sera Y., Okochi T., Yamamura Y. Letter: T lymphocytes in abestosis. N Engl J Med. 1974 Oct 3;291(14):735–736. doi: 10.1056/NEJM197410032911414. [DOI] [PubMed] [Google Scholar]
  45. Keeling B., Li K. Y., Churg A. Iron enhances uptake of mineral particles and increases lipid peroxidation in tracheal epithelial cells. Am J Respir Cell Mol Biol. 1994 Jun;10(6):683–688. doi: 10.1165/ajrcmb.10.6.8003344. [DOI] [PubMed] [Google Scholar]
  46. Kennedy T. P., Dodson R., Rao N. V., Ky H., Hopkins C., Baser M., Tolley E., Hoidal J. R. Dusts causing pneumoconiosis generate .OH and produce hemolysis by acting as Fenton catalysts. Arch Biochem Biophys. 1989 Feb 15;269(1):359–364. doi: 10.1016/0003-9861(89)90118-5. [DOI] [PubMed] [Google Scholar]
  47. Kheradmand F., Folkesson H. G., Shum L., Derynk R., Pytela R., Matthay M. A. Transforming growth factor-alpha enhances alveolar epithelial cell repair in a new in vitro model. Am J Physiol. 1994 Dec;267(6 Pt 1):L728–L738. doi: 10.1152/ajplung.1994.267.6.L728. [DOI] [PubMed] [Google Scholar]
  48. Kopp E. B., Ghosh S. NF-kappa B and rel proteins in innate immunity. Adv Immunol. 1995;58:1–27. doi: 10.1016/s0065-2776(08)60618-5. [DOI] [PubMed] [Google Scholar]
  49. Korfhagen T. R., Swantz R. J., Wert S. E., McCarty J. M., Kerlakian C. B., Glasser S. W., Whitsett J. A. Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. J Clin Invest. 1994 Apr;93(4):1691–1699. doi: 10.1172/JCI117152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Kubota M., Kagamimori S., Yokoyama K., Okada A. Reduced killer cell activity of lymphocytes from patients with asbestosis. Br J Ind Med. 1985 Apr;42(4):276–280. doi: 10.1136/oem.42.4.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Kunkel S. L., Standiford T., Kasahara K., Strieter R. M. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res. 1991 Jan-Feb;17(1):17–23. doi: 10.3109/01902149109063278. [DOI] [PubMed] [Google Scholar]
  52. Lange A., Skibiński G., Garncarek D. The follow-up study of skin reactivity to recall antigens and E- and EAC-RFC profiles in blood in asbestos workers. Immunobiology. 1980 Apr;157(1):1–11. doi: 10.1016/S0171-2985(80)80056-8. [DOI] [PubMed] [Google Scholar]
  53. Lange A., Smolik R., Chmielarczyk W., Garncarek D., Gielgier Z. Cellular immunity in asbestosis. Arch Immunol Ther Exp (Warsz) 1978;26(1-6):899–903. [PubMed] [Google Scholar]
  54. Lange A., Smolik R., Zatoński W., Szymańska J. Autoantibodies and serum immunoglobulin levels in asbestos workers. Int Arch Arbeitsmed. 1974 Jan 31;32(4):313–325. doi: 10.1007/BF02178970. [DOI] [PubMed] [Google Scholar]
  55. Lanier L. L., Phillips J. H., Hackett J., Jr, Tutt M., Kumar V. Natural killer cells: definition of a cell type rather than a function. J Immunol. 1986 Nov 1;137(9):2735–2739. [PubMed] [Google Scholar]
  56. Larsson R., Cerutti P. Oxidants induce phosphorylation of ribosomal protein S6. J Biol Chem. 1988 Nov 25;263(33):17452–17458. [PubMed] [Google Scholar]
  57. Laszlo P. Chemical reactions on clays. Science. 1987 Mar 20;235(4795):1473–1477. doi: 10.1126/science.235.4795.1473. [DOI] [PubMed] [Google Scholar]
  58. Lehnert B. E. Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung. Environ Health Perspect. 1992 Jul;97:17–46. doi: 10.1289/ehp.929717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Lemaire I., Beaudoin H., Massé S., Grondin C. Alveolar macrophage stimulation of lung fibroblast growth in asbestos-induced pulmonary fibrosis. Am J Pathol. 1986 Feb;122(2):205–211. [PMC free article] [PubMed] [Google Scholar]
  60. Lemaire I., Dionne P. G., Nadeau D., Dunnigan J. Rat lung reactivity to natural and man-made fibrous silicates following short-term exposure. Environ Res. 1989 Apr;48(2):193–210. doi: 10.1016/s0013-9351(89)80034-9. [DOI] [PubMed] [Google Scholar]
  61. Lemaire I., Dubois C. In vitro suppression of fibroblast growth inhibitory lymphokine production by asbestos. Clin Exp Immunol. 1983 Jul;53(1):239–248. [PMC free article] [PubMed] [Google Scholar]
  62. Lemaire I., Ouellet S. Distinctive profile of alveolar macrophage-derived cytokine release induced by fibrogenic and nonfibrogenic mineral dusts. J Toxicol Environ Health. 1996 Apr 5;47(5):465–478. doi: 10.1080/009841096161618. [DOI] [PubMed] [Google Scholar]
  63. Lemaire I., Yang H. Colony stimulating factors induce alveolar macrophage differentiation and giant cell formation. Ann N Y Acad Sci. 1996 Oct 31;796:173–181. doi: 10.1111/j.1749-6632.1996.tb32578.x. [DOI] [PubMed] [Google Scholar]
  64. Leslie C. C., McCormick-Shannon K., Cook J. L., Mason R. J. Macrophages stimulate DNA synthesis in rat alveolar type II cells. Am Rev Respir Dis. 1985 Dec;132(6):1246–1252. doi: 10.1164/arrd.1985.132.6.1246. [DOI] [PubMed] [Google Scholar]
  65. Liu J. Y., Morris G. F., Lei W. H., Corti M., Brody A. R. Up-regulated expression of transforming growth factor-alpha in the bronchiolar-alveolar duct regions of asbestos-exposed rats. Am J Pathol. 1996 Jul;149(1):205–217. [PMC free article] [PubMed] [Google Scholar]
  66. Lund L. G., Aust A. E. Iron-catalyzed reactions may be responsible for the biochemical and biological effects of asbestos. Biofactors. 1991 Jun;3(2):83–89. [PubMed] [Google Scholar]
  67. Lund L. G., Williams M. G., Dodson R. F., Aust A. E. Iron associated with asbestos bodies is responsible for the formation of single strand breaks in phi X174 RFI DNA. Occup Environ Med. 1994 Mar;51(3):200–204. doi: 10.1136/oem.51.3.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Manning L. S., Bowman R. V., Darby S. B., Robinson B. W. Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cells. Am Rev Respir Dis. 1989 Jun;139(6):1369–1374. doi: 10.1164/ajrccm/139.6.1369. [DOI] [PubMed] [Google Scholar]
  69. Matsusaka T., Fujikawa K., Nishio Y., Mukaida N., Matsushima K., Kishimoto T., Akira S. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10193–10197. doi: 10.1073/pnas.90.21.10193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Meyer M., Pahl H. L., Baeuerle P. A. Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem Biol Interact. 1994 Jun;91(2-3):91–100. doi: 10.1016/0009-2797(94)90029-9. [DOI] [PubMed] [Google Scholar]
  71. Miller K., Weintraub Z., Kagan E. Manifestations of cellular immunity in the rat after prolonged asbestos inhalation. I. Physical interactions between alveolar macrophages and splenic lymphocytes. J Immunol. 1979 Sep;123(3):1029–1038. [PubMed] [Google Scholar]
  72. Morris G. F., Liu J. Y., Lei W. H., Brody A. R. Expression of genes coding for growth factors in experimental pneumoconiosis. Chest. 1996 Mar;109(3 Suppl):45S–49S. doi: 10.1378/chest.109.3_supplement.45s-a. [DOI] [PubMed] [Google Scholar]
  73. Mossman B. T., Marsh J. P., Sesko A., Hill S., Shatos M. A., Doherty J., Petruska J., Adler K. B., Hemenway D., Mickey R. Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respir Dis. 1990 May;141(5 Pt 1):1266–1271. doi: 10.1164/ajrccm/141.5_Pt_1.1266. [DOI] [PubMed] [Google Scholar]
  74. Mukaida N., Mahe Y., Matsushima K. Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem. 1990 Dec 5;265(34):21128–21133. [PubMed] [Google Scholar]
  75. Mukaida N., Okamoto S., Ishikawa Y., Matsushima K. Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol. 1994 Nov;56(5):554–558. [PubMed] [Google Scholar]
  76. Nash D. R., Fortson N. G., McLarty J. W., Hurst G. A. Serum protein concentrations and respiratory tract abnormalities following short-term exposure to amosite: a comparison between former asbestos workers and unexposed controls. J Toxicol Environ Health. 1981 May;7(5):733–744. doi: 10.1080/15287398109530015. [DOI] [PubMed] [Google Scholar]
  77. Ouellet S., Yang H., Aubin R. A., Hawley R. G., Wenckebach G. F., Lemaire I. Bidirectional modulation of TNF-alpha production by alveolar macrophages in asbestos-induced pulmonary fibrosis. J Leukoc Biol. 1993 Mar;53(3):279–286. doi: 10.1002/jlb.53.3.279. [DOI] [PubMed] [Google Scholar]
  78. Pahl H. L., Baeuerle P. A. Oxygen and the control of gene expression. Bioessays. 1994 Jul;16(7):497–502. doi: 10.1002/bies.950160709. [DOI] [PubMed] [Google Scholar]
  79. Paller M. S., Neumann T. V. Reactive oxygen species and rat renal epithelial cells during hypoxia and reoxygenation. Kidney Int. 1991 Dec;40(6):1041–1049. doi: 10.1038/ki.1991.312. [DOI] [PubMed] [Google Scholar]
  80. Palombella V. J., Mendelsohn J., Vilcek J. Mitogenic action of tumor necrosis factor in human fibroblasts: interaction with epidermal growth factor and platelet-derived growth factor. J Cell Physiol. 1988 Apr;135(1):23–31. doi: 10.1002/jcp.1041350104. [DOI] [PubMed] [Google Scholar]
  81. Perkins R. C., Scheule R. K., Hamilton R., Gomes G., Freidman G., Holian A. Human alveolar macrophage cytokine release in response to in vitro and in vivo asbestos exposure. Exp Lung Res. 1993 Jan-Mar;19(1):55–65. doi: 10.3109/01902149309071080. [DOI] [PubMed] [Google Scholar]
  82. Pernis B., Vigliani E. C., Selikoff I. J. Rheumatoid factor in serum of individuals exposed to asbestos. Ann N Y Acad Sci. 1965 Dec 31;132(1):112–120. doi: 10.1111/j.1749-6632.1965.tb41094.x. [DOI] [PubMed] [Google Scholar]
  83. Petruska J. M., Marsh J., Bergeron M., Mossman B. T. Brief inhalation of asbestos compromises superoxide production in cells from bronchoalveolar lavage. Am J Respir Cell Mol Biol. 1990 Feb;2(2):129–136. doi: 10.1165/ajrcmb/2.2.129. [DOI] [PubMed] [Google Scholar]
  84. Piguet P. F., Collart M. A., Grau G. E., Sappino A. P., Vassalli P. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature. 1990 Mar 15;344(6263):245–247. doi: 10.1038/344245a0. [DOI] [PubMed] [Google Scholar]
  85. Piguet P. F., Grau G. E., Vassalli P. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis. Am J Pathol. 1990 Jan;136(1):103–110. [PMC free article] [PubMed] [Google Scholar]
  86. Prieditis H., Adamson I. Y. Alveolar macrophage kinetics and multinucleated giant cell formation after lung injury. J Leukoc Biol. 1996 Apr;59(4):534–538. doi: 10.1002/jlb.59.4.534. [DOI] [PubMed] [Google Scholar]
  87. Rebuck A. S., Braude A. C. Bronchoalveolar lavage in asbestosis. Arch Intern Med. 1983 May;143(5):950–952. [PubMed] [Google Scholar]
  88. Robinson B. W., Rose A. H., James A., Whitaker D., Musk A. W. Alveolitis of pulmonary asbestosis. Bronchoalveolar lavage studies in crocidolite- and chrysotile-exposed individuals. Chest. 1986 Sep;90(3):396–402. doi: 10.1378/chest.90.3.396. [DOI] [PubMed] [Google Scholar]
  89. Rolfe M. W., Kunkel S. L., Standiford T. J., Chensue S. W., Allen R. M., Evanoff H. L., Phan S. H., Strieter R. M. Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking. Am J Respir Cell Mol Biol. 1991 Nov;5(5):493–501. doi: 10.1165/ajrcmb/5.5.493. [DOI] [PubMed] [Google Scholar]
  90. Rom W. N., Basset P., Fells G. A., Nukiwa T., Trapnell B. C., Crysal R. G. Alveolar macrophages release an insulin-like growth factor I-type molecule. J Clin Invest. 1988 Nov;82(5):1685–1693. doi: 10.1172/JCI113781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Rom W. N., Bitterman P. B., Rennard S. I., Cantin A., Crystal R. G. Characterization of the lower respiratory tract inflammation of nonsmoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dusts. Am Rev Respir Dis. 1987 Dec;136(6):1429–1434. doi: 10.1164/ajrccm/136.6.1429. [DOI] [PubMed] [Google Scholar]
  92. Rom W. N., Päkkö P. Activated alveolar macrophages express the insulin-like growth factor-I receptor. Am J Respir Cell Mol Biol. 1991 May;4(5):432–439. doi: 10.1165/ajrcmb/4.5.432. [DOI] [PubMed] [Google Scholar]
  93. Rom W. N., Travis W. D., Brody A. R. Cellular and molecular basis of the asbestos-related diseases. Am Rev Respir Dis. 1991 Feb;143(2):408–422. doi: 10.1164/ajrccm/143.2.408. [DOI] [PubMed] [Google Scholar]
  94. Rom W. N., Travis W. D., Brody A. R. Cellular and molecular basis of the asbestos-related diseases. Am Rev Respir Dis. 1991 Feb;143(2):408–422. doi: 10.1164/ajrccm/143.2.408. [DOI] [PubMed] [Google Scholar]
  95. Rom W. N., Travis W. D. Lymphocyte-macrophage alveolitis in nonsmoking individuals occupationally exposed to asbestos. Chest. 1992 Mar;101(3):779–786. doi: 10.1378/chest.101.3.779. [DOI] [PubMed] [Google Scholar]
  96. Roney P. L., Holian A. Possible mechanism of chrysotile asbestos-stimulated superoxide anion production in guinea pig alveolar macrophages. Toxicol Appl Pharmacol. 1989 Aug;100(1):132–144. doi: 10.1016/0041-008x(89)90097-5. [DOI] [PubMed] [Google Scholar]
  97. Rosenthal G. J., Germolec D. R., Blazka M. E., Corsini E., Simeonova P., Pollock P., Kong L. Y., Kwon J., Luster M. I. Asbestos stimulates IL-8 production from human lung epithelial cells. J Immunol. 1994 Oct 1;153(7):3237–3244. [PubMed] [Google Scholar]
  98. Ross R., Raines E. W., Bowen-Pope D. F. The biology of platelet-derived growth factor. Cell. 1986 Jul 18;46(2):155–169. doi: 10.1016/0092-8674(86)90733-6. [DOI] [PubMed] [Google Scholar]
  99. Santoli D., Koprowski H. Mechanisms of activation of human natural killer cells against tumor and virus-infected cells. Immunol Rev. 1979;44:125–163. doi: 10.1111/j.1600-065x.1979.tb00269.x. [DOI] [PubMed] [Google Scholar]
  100. Schapira R. M., Ghio A. J., Effros R. M., Morrisey J., Dawson C. A., Hacker A. D. Hydroxyl radicals are formed in the rat lung after asbestos instillation in vivo. Am J Respir Cell Mol Biol. 1994 May;10(5):573–579. doi: 10.1165/ajrcmb.10.5.8179922. [DOI] [PubMed] [Google Scholar]
  101. Schreck R., Albermann K., Baeuerle P. A. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun. 1992;17(4):221–237. doi: 10.3109/10715769209079515. [DOI] [PubMed] [Google Scholar]
  102. Schreck R., Rieber P., Baeuerle P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991 Aug;10(8):2247–2258. doi: 10.1002/j.1460-2075.1991.tb07761.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Simeonova P. P., Luster M. I. Asbestos induction of nuclear transcription factors and interleukin 8 gene regulation. Am J Respir Cell Mol Biol. 1996 Dec;15(6):787–795. doi: 10.1165/ajrcmb.15.6.8969274. [DOI] [PubMed] [Google Scholar]
  104. Simeonova P. P., Luster M. I. Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages. Am J Respir Cell Mol Biol. 1995 Jun;12(6):676–683. doi: 10.1165/ajrcmb.12.6.7539275. [DOI] [PubMed] [Google Scholar]
  105. Simeonova P. P., Toriumi W., Kommineni C., Erkan M., Munson A. E., Rom W. N., Luster M. I. Molecular regulation of IL-6 activation by asbestos in lung epithelial cells: role of reactive oxygen species. J Immunol. 1997 Oct 15;159(8):3921–3928. [PubMed] [Google Scholar]
  106. Smith R. E., Strieter R. M., Phan S. H., Kunkel S. L. C-C chemokines: novel mediators of the profibrotic inflammatory response to bleomycin challenge. Am J Respir Cell Mol Biol. 1996 Dec;15(6):693–702. doi: 10.1165/ajrcmb.15.6.8969262. [DOI] [PubMed] [Google Scholar]
  107. Sorokin S. P., McNelly N. A., Hoyt R. F., Jr Macrophage development: IV. Effects of blood factors on macrophages from prenatal rat lung cultures. Anat Rec. 1992 Jul;233(3):415–428. doi: 10.1002/ar.1092330309. [DOI] [PubMed] [Google Scholar]
  108. Sprince N. L., Oliver L. C., McLoud T. C., Eisen E. A., Christiani D. C., Ginns L. C. Asbestos exposure and asbestos-related pleural and parenchymal disease. Associations with immune imbalance. Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):822–828. doi: 10.1164/ajrccm/143.4_Pt_1.822. [DOI] [PubMed] [Google Scholar]
  109. Spurzem J. R., Saltini C., Rom W., Winchester R. J., Crystal R. G. Mechanisms of macrophage accumulation in the lungs of asbestos-exposed subjects. Am Rev Respir Dis. 1987 Aug;136(2):276–280. doi: 10.1164/ajrccm/136.2.276. [DOI] [PubMed] [Google Scholar]
  110. Standiford T. J., Kunkel S. L., Phan S. H., Rollins B. J., Strieter R. M. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem. 1991 May 25;266(15):9912–9918. [PubMed] [Google Scholar]
  111. Standiford T. J., Rolfe M. W., Kunkel S. L., Lynch J. P., 3rd, Burdick M. D., Gilbert A. R., Orringer M. B., Whyte R. I., Strieter R. M. Macrophage inflammatory protein-1 alpha expression in interstitial lung disease. J Immunol. 1993 Sep 1;151(5):2852–2863. [PubMed] [Google Scholar]
  112. Stansfield D., Edge J. R. Circulating rheumatoid factor and antinuclear antibodies in shipyard asbestos workers with pleural plaques. Br J Dis Chest. 1974 Jul;68(0):166–170. doi: 10.1016/0007-0971(74)90034-5. [DOI] [PubMed] [Google Scholar]
  113. Stein B., Baldwin A. S., Jr Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B. Mol Cell Biol. 1993 Nov;13(11):7191–7198. doi: 10.1128/mcb.13.11.7191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Takemura T., Rom W. N., Ferrans V. J., Crystal R. G. Morphologic characterization of alveolar macrophages from subjects with occupational exposure to inorganic particles. Am Rev Respir Dis. 1989 Dec;140(6):1674–1685. doi: 10.1164/ajrccm/140.6.1674. [DOI] [PubMed] [Google Scholar]
  115. Tsang P. H., Chu F. N., Fischbein A., Bekesi J. G. Impairments in functional subsets of T-suppressor (CD8) lymphocytes, monocytes, and natural killer cells among asbestos-exposed workers. Clin Immunol Immunopathol. 1988 Jun;47(3):323–332. doi: 10.1016/s0090-1229(88)80009-6. [DOI] [PubMed] [Google Scholar]
  116. Tsang P. H., Chu F. N., Fischbein A., Bekesi J. G. Impairments in functional subsets of T-suppressor (CD8) lymphocytes, monocytes, and natural killer cells among asbestos-exposed workers. Clin Immunol Immunopathol. 1988 Jun;47(3):323–332. doi: 10.1016/s0090-1229(88)80009-6. [DOI] [PubMed] [Google Scholar]
  117. Turner-Warwick M., Parkes W. R. Circulating rheumatoid and antinuclear factors in asbestos workers. Br Med J. 1970 Aug 29;3(5721):492–495. doi: 10.1136/bmj.3.5721.492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Ueki A., Oka T., Mochizuki Y. Proliferation stimulating effects of chrysotile and crocidolite asbestos fibres on B lymphocyte cell lines. Clin Exp Immunol. 1984 May;56(2):425–430. [PMC free article] [PubMed] [Google Scholar]
  119. Vanhée D., Molet S., Gosset P., Tillie-Leblond I., Boitelle A., Wallaert B., Tonnel A. B. Expression of leucocyte-endothelial adhesion molecules is limited to intercellular adhesion molecule-1 (ICAM-1) in the lung of pneumoconiotic patients: role of tumour necrosis factor-alpha (TNF-alpha). Clin Exp Immunol. 1996 Dec;106(3):541–548. doi: 10.1046/j.1365-2249.1996.d01-878.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Wallace J. M., Oishi J. S., Barbers R. G., Batra P., Aberle D. R. Bronchoalveolar lavage cell and lymphocyte phenotype profiles in healthy asbestos-exposed shipyard workers. Am Rev Respir Dis. 1989 Jan;139(1):33–38. doi: 10.1164/ajrccm/139.1.33. [DOI] [PubMed] [Google Scholar]
  121. Warheit D. B., Hill L. H., George G., Brody A. R. Time course of chemotactic factor generation and the corresponding macrophage response to asbestos inhalation. Am Rev Respir Dis. 1986 Jul;134(1):128–133. doi: 10.1164/arrd.1986.134.1.128. [DOI] [PubMed] [Google Scholar]
  122. Warheit D. B., Overby L. H., George G., Brody A. R. Pulmonary macrophages are attracted to inhaled particles through complement activation. Exp Lung Res. 1988;14(1):51–66. doi: 10.3109/01902148809062850. [DOI] [PubMed] [Google Scholar]
  123. Wessells N. K., Spooner B. S., Ash J. F., Bradley M. O., Luduena M. A., Taylor E. L., Wrenn J. T., Yamada K. Microfilaments in cellular and developmental processes. Science. 1971 Jan 15;171(3967):135–143. doi: 10.1126/science.171.3967.135. [DOI] [PubMed] [Google Scholar]
  124. Zhang Y., Lee T. C., Guillemin B., Yu M. C., Rom W. N. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol. 1993 May 1;150(9):4188–4196. [PubMed] [Google Scholar]
  125. al Jarad N., Gellert A. R., Rudd R. M. Bronchoalveolar lavage and 99mTc-DTPA clearance as prognostic factors in asbestos workers with and without asbestosis. Respir Med. 1993 Jul;87(5):365–374. doi: 10.1016/0954-6111(93)90050-a. [DOI] [PubMed] [Google Scholar]
  126. deShazo R. D., Nordberg J., Baser Y., Bozelka B., Weill H., Salvaggio J. Analysis of depressed cell-mediated immunity in asbestos workers. J Allergy Clin Immunol. 1983 Apr;71(4):418–424. doi: 10.1016/0091-6749(83)90072-6. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES